| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific &Dev. Ofc.
1 company
Jayagopal Ashwath serves as a Chief Scientific &Dev. Ofc. at IRD. Across recent SEC filings that breaks down to 1 buy and 2 sells. Those positions are worth an estimated $2.6M at current prices.
The biggest single holding is IRD (~$2.6M) as Chief Scientific &Dev. Ofc.. The recent filings there lean toward selling, a net 7,761 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | IRD Opus Genetics, Inc. | Chief Scientific &Dev. Ofc. | Sell | 7,542 | $5.19 | $39,155.80 | -1.5% | - | - | |
| Mar 16, 2026 | IRD Opus Genetics, Inc. | Chief Scientific &Dev. Ofc. | Sell | 3,719 | $5.12 | $19,046.11 | -0.7% | - | - | |
| May 22, 2024 | IRD Opus Genetics, Inc. | Chief Scientific &Dev. Ofc. | Buy | 3,500 | $1.77 | $6,177.50 | +4.7% | -25.4% | -42.9% |